INNOVA CAPTAB LIMITED (INNOVACAP) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.[1]

INNOVACAPUpdated 31 Aug 2026, 18:32

Innova Captab Limited

Market Cap

₹6,171Cr.

Current Price

₹1,078

High / Low

₹1,122/608

Stock P/E

64.6

ROE9.85%
ROCE10.8%
Book Value₹155
Face Value₹10.0
Dividend Yield0.19%

About

Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days851238198929593
Inventory Days8410763676894103
Days Payable9213284102111119145
Cash Conversion Cycle77996063497051
Working Capital Days45392344586582
ROCE %28%33%21%15%12%11%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 18:32


Designed & Shipped by Harshit Bansal